MUSCAT – Organised by the Oman Society of Oncology and the National Oncology Centre in cooperation with the Sultan Qaboos Comprehensive Centre for Cancer Treatment and Research, the conference’s opening was patronised by His Excellency Dr Saleh bin Salem Al-Rahbi, Advisor at the Royal Court.

At the conclusion of proceedings, participants emphasised the importance of advanced genetic testing (NGS) in determining disease prognosis and selecting personalised treatment plans. They also highlighted the necessity of aligning with international guidelines, particularly those issued by American and European institutions.

Experts at the conference underlined the pivotal role of immunotherapy and targeted therapy in improving outcomes for lung and breast cancers, among others, and stressed the value of multidisciplinary collaboration to deliver integrated, evidence-based care. The event also called for sustained support for scientific research and international cooperation to enhance healthcare quality and improve recovery rates for cancer patients.

Preceding the main sessions, a series of workshops and specialised training programmes were held, focusing on cutting-edge tumour diagnosis and treatment techniques. These sessions brought together leading consultants and experts from Oman and abroad, facilitating the exchange of expertise and enhancing the knowledge of participating medical personnel.

The conference attracted an elite group of oncology specialists from Oman, Europe, the United States, and China, as well as regional leaders, highlighting the rapid progress in the field and the growing importance of knowledge exchange in one of medicine’s most precise disciplines.

Key discussions included the latest treatment strategies in immunotherapy and targeted therapy, particularly for lung cancer at various stages, as well as recent global advances in breast cancer management. Participants reviewed prominent recommendations from major international conferences, reflecting the fast-evolving nature of oncology practice.

Dr Suad bint Sulaiman Al Kharousi, President of the Oman Society of Oncology, described the conference as a milestone in Gulf oncology since its inception in 2009. She noted that the event represents the collaborative efforts of Omani health institutions to unify expertise and enhance cancer treatment services, even amid global challenges such as geopolitical tensions, health crises, and climatic events.

Dr Al Kharousi added that the conference hosts distinguished experts from Oman, the US, the UK and Ireland, as well as regional leaders from Egypt, the UAE, and Kuwait. She expressed confidence that the working papers and discussions on last year’s notable developments would directly inform daily clinical practice and generate significant scientific value for participants.

The opening ceremony featured a visual presentation and a lecture on the role of community support in cancer care. Conference sessions also covered innovations in early diagnosis, clinical trials, and international best practices, all aimed at improving healthcare quality and treatment efficiency.